293 filings
Page 5 of 15
6-K
97u5mlukvi08 r3re
9 Sep 19
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
8:41am
6-K
5pj 3nh2sidngd2ax0
4 Sep 19
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
9:00am
6-K
6heykmw
28 Aug 19
Current report (foreign)
4:05pm
6-K
xrd 4q5jobho7hn5d661
14 Aug 19
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020
12:00am
6-K
0gn9v3cazncqjh lo
14 Aug 19
Current report (foreign)
12:00am
6-K
npe0b
9 Aug 19
Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference
8:00am
6-K
cpdg75xqvc5yz
7 Aug 19
Acasti Pharma Schedules First Quarter Fiscal 2020 Conference Call
8:00am
6-K
va5jmz
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
isgxcwry8cebqnd
25 Jul 19
Current report (foreign)
3:56pm
6-K
gbe5uu10
5 Jul 19
Current report (foreign)
9:00am
6-K
m9q r75585qd
26 Jun 19
Acasti Pharma Provides Fiscal 2019 Year-End Business Update
8:06am
6-K
8rl12iw1y9rq00vwrqj9
24 Jun 19
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
9:01am
6-K
kr9mh
19 Jun 19
Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call
8:00am
6-K
ghybubo nfsrami3x
4 Jun 19
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia
9:15am
6-K
g90d729r
21 May 19
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
7:31am
6-K
cdjb5iek483u9wtgcbm
15 May 19
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
7:56am
6-K
j9cg6scholfc7 cb64g
10 May 19
Current report (foreign)
10:05am
6-K
gi1kc0xonw7y clvd
24 Apr 19
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
8:35am
6-K
hwm mpvhdaof64oi7
15 Apr 19
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
9:15am
6-K
cj5dz6cuhf n4nl9l9i
26 Mar 19
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
8:30am